Lazard Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 1 to 10 of 4012 Results
June 01, 2026
Servier to Acquire Edgewise Therapeutics’ Muscular Dystrophy Business
$2.6 Billion
June 01, 2026
Waldencast Announces Sale of Obagi Medical to Bridgepoint
$460 Million
May 29, 2026
Bite Group agrees to sell and lease back its towers infrastructure in Lithuania and Latvia
$563.4 Million
May 29, 2026
NCC Group announces the sale of its Escode business to TDR Capital LLP, creating a pure-play global Cyber security and resilience business
$368.7 Million
May 26, 2026
Vaccine Company to be acquired by Lilly to advance best-in-class vaccine candidates for Epstein-Barr Virus and other infectious diseases
$1.5 Billion
May 25, 2026
Frances Loxam to buy controlling stake in Brazils Mills
$1 Billion
May 21, 2026
Sun Communities, Inc. Announces Agreement To Sell UK Assets For Approximately $1.03 Billion In An All-Cash Transaction
$1 Billion
May 21, 2026
Lazard acted as exclusive financial advisor to Kayrros on the sale of its defence activities to Safran.AI
Undisclosed
May 21, 2026
Energy Aspects agrees to acquire Kayrros
Undisclosed
May 19, 2026